مواقع التدريسيينجامعة الكوفة
fadhil abduljabbar rizij Al-basrawy
Professor

fadhil abduljabbar rizij Al-basrawy

0Publications
0Lectures

About

Educational Back ground
*Ph.D. Pharmacology and therapeutics \ colloge of medicine\ Al-Nahrain University
*Master degree Pharmacology and therapeutics\ colloge of medicine\ Al-Kufa University
*B.Sc. pharmacy from College of pharmacy \ Al-Kufa University
Teaching Experiences:
1-Pharmacology
2- Clinical Toxicology
3-Pharmaceutical Technology
4-Biopharmaceutics
5-Clinical Pharmacy
Research Experience:
1. Study the effect of antioxidants on atherosclerosis.
2. Study the effect of anti inflammatory drugs on atherosclerosis
3. Study of the adverse effects of different drugs
Publications:
1. Effects of glimepiride and repaglinide on atherosclerosis progression in high cholesterol male rabbits. 2012
2. Effects of amlopine on atherosclerosis progression in high cholesterol male rabbits . 2015
3. Effects of sitagliptin on atherosclerosis progression in high cholesterol male rabbits. 2015

Publications

3
2014

Evaluation the Effects of Sitagliptin on Atherosclerosis Progression in High CholesterolFed Male Rabbits

AuthorsHamoudi Aliwi Mosah1,, Yahya Y.Z. Fareed2 , Hayder B Sahib3, Fadhil A. Rizij4*
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Abstract

ABSTRACT The aim of the study was to assess the effect of sitagliptin on atherosclerosis via interfering with inflammatory and oxidative pathways. Twenty four local domestic male rabbits were involved in this study. The animals were randomly divided into three groups, Group I rabbits fed normal chow (oxiod) diet for 12 weeks. Group II rabbits fed with 1% cholesterol enriched diet. Group III rabbits fed with 1% cholesterol enriched diet together with sitagliptin (10 mg/kg once daily before morning feed). Blood samples were collected before (0 time) and every four weeks of experimental diets for measurement of serum triglycerides, total cholesterol, high density lipoprotein cholesterol, high sensitive C-Reactive Protein, endothelin-1 and intracellular adhesion molecule-1 level. At the end of 12 weeks the aorta was removed for measurement of aortic Malondialdehyde, reduced glutathione and aortic intimal thickness. Sitagliptin treatment did show a non significant effect on lipid parameters compared with induced untreated group (P > 0.05). It was significantly reduced the elevation in high sensitive C-Reactive Protein, endothelin-1, intracellular adhesion molecule-1 level, aortic MDA and aortic intimal thickness compared with induced untreated group (P < 0.05), and they restore aortic reduced glutathione level (P < 0.05). Sitagliptin may reduce atherosclerosis progression in hyper cholesterolemic rabbit via interfering with inflammatory and oxidative pathways without affecting lipid parameters. Keywords: Atherosclerosis, Inflammatory markers, Oxidative stress, Sitagliptin

2014

Evaluation the Effects of Amlodipine on Atherosclerosis Progression in High CholesterolFed Male Rabbits.

Authors1Hamoudi Aliwi Mosa, j , 2Yahya Y.Z. Fareed, 3Hayder B Sahib, 4Fadhil A. Rizi
JournalInternational Journal of Pharmaceutical Sciences Review and Research
Abstract

ABSTRACT The objective of present study was to assess the effect of amlodipine on atherosclerosis via interfering with inflammatory and oxidative pathways. Twenty four local domestic male rabbits were involved in this study. The animals were randomly divided into three groups which include: Group I rabbits fed normal chow (oxiod) diet for 12 weeks. Group II rabbits fed with 1% cholesterol enriched diet. Group III rabbits fed with 1% cholesterol enriched diet together with amlodipine (5 mg/kg once daily before morning feed). Blood samples were collected before zero time and every four weeks of experimental diets for measurement of serum triglycerides, total cholesterol, high density lipoprotein cholesterol, high sensitive C-Reactive Protein, endothelin-1 and intracellular adhesion molecule-1 level. At the end of 12 weeks the aorta was removed for measurement of aortic Malondialdehyde, reduced glutathione and aortic intimal thickness. Amlodipine treatment did show an insignificant effect on lipid parameters compared with induced untreated group (P > 0.05). While it was significantly reduced the elevation in endothelin-1, high sensitive C-Reactive Protein, intracellular adhesion molecule-1 level, aortic MDA and aortic intimal thickness compared with induced untreated group (P < 0.05), and they restore aortic reduced glutathione level (P < 0.05). Amlodipine may decrease atherosclerosis progression in hypercholesterolemic rabbit via interfering with oxidative and inflammatory pathways without affecting lipid parameters. Keywords: amlodipine, inflammatory markers, oxidative stress, atherosclerosis.

2012

Evaluation of the effects of glimepiride (Amaryl) and repaglinide (novoNorm) on atherosclerosis progression in high cholesterol-fed male rabbits

AuthorsNajah R. Hadi, , Fadhil Al-Amran,1 Mohammad A. A. Hussein,2 and Fadhil A. Rezeg
JournalJournal of Cardiovascular Disease Research
Abstract

Background: Atherosclerosis is an inflammatory disease of the blood vessel wall, characterized in early stages by endothelial dysfunction, recruitment and activation of monocyte/macrophages. Glimepiride is one of the third generation sulphonylurea drugs, useful for control of diabetes mellitus type two and it may exert anti inflammatory activity, by induction of nitric oxide production or through selective suppression of the cyclooxygenase pathway. Repaglinide is a new hypoglycemic agent, and a member of the carbamoylmethyl benzoic acid family. Some results from the literature demonstrate that repaglinide has favorable effects on the parameters of antioxidative balance. Objectives: The objective of the present study was to assess the effect of glimepiride and repaglinide on atherosclerosis via interfering with the inflammatory and oxidative pathways. Materials and Methods: Twenty four local domestic male rabbits were involved in this study. The animals were randomly divided into four groups; Group I rabbits fed normal chow (oxiod) diet for 10 weeks. Group II rabbits were fed with 1% cholesterol enriched diet. Group III rabbits were fed with 1% cholesterol enriched diet together with Glimepiride (0.1 mg/kg once daily before morning feed). Group IV rabbits were fed with 1% cholesterol enriched diet together with Repaglinide (0.3 mg/kg once daily before morning feed). Blood samples were collected before (0 time) and every two weeks of experimental diets for measurement of serum triglycerides (TG), total cholesterol (TC), High-density lipoprotein cholesterol (HDL-C), high sensitive C - reactive protein (hsCRP), Interleukin – 6 (IL-6) and Tumor Necrosis Factor alpha (TNF-α) levels. At the end of 10 weeks, the aorta was removed for measurement of aortic Malondialdehyde (MDA), reduced glutathione (GSH) and aortic intimal thickness. Results: Glimepiride and repaglinide treatment did show significant effect on lipid parameters compared with induced untreated group (P < 0.05). Also, they significantly reduced the elevation in hsCRP, IL-6, TNF-α, aortic MDA and aortic intimal thickness compared with induced untreated group (P < 0.05), and they helped to restore the aortic GSH levels (P < 0.05). Conclusions: Glimepiride and repaglinide may reduce atherosclerosis progression in hypercholesterolemic rabbits by interfering with the inflammatory and oxidative pathways without affecting lipid parameters. Keywords: Atherosclerosis, glimepiride, inflammatory markers, oxidative stress, repaglinid

Lectures

2
View details